Total Payments
$25,811
2024 Payments
$3,189
Companies
78
Transactions
1,529
Medicare Patients
16,664
Medicare Billing
$829,887
Payment Breakdown by Category
Food & Beverage$23,572 (91.3%)
Consulting$2,070 (8.0%)
Gifts$69.00 (0.3%)
Other$53.04 (0.2%)
Education$46.06 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,572 | 1,518 | 91.3% |
| Consulting Fee | $2,070 | 2 | 8.0% |
| Gift | $69.00 | 1 | 0.3% |
| Debt forgiveness | $53.04 | 1 | 0.2% |
| Education | $46.06 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,118 | 159 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,889 | 106 | $0 (2024) |
| Lilly USA, LLC | $1,850 | 131 | $0 (2024) |
| PFIZER INC. | $1,380 | 101 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,363 | 9 | $0 (2021) |
| ABBVIE INC. | $1,260 | 84 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,240 | 117 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,087 | 82 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,052 | 79 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,045 | 69 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,189 | 128 | Lilly USA, LLC ($579.96) |
| 2023 | $4,085 | 168 | Novo Nordisk Inc ($1,227) |
| 2022 | $3,223 | 177 | ABBVIE INC. ($378.73) |
| 2021 | $4,520 | 213 | Biohaven Pharmaceuticals, Inc. ($1,363) |
| 2020 | $2,175 | 145 | Amarin Pharma Inc. ($315.47) |
| 2019 | $2,597 | 211 | AstraZeneca Pharmaceuticals LP ($338.20) |
| 2018 | $3,032 | 249 | AstraZeneca Pharmaceuticals LP ($341.55) |
| 2017 | $2,989 | 238 | AstraZeneca Pharmaceuticals LP ($466.65) |
All Payment Transactions
1,529 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Biological | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $113.20 | General |
| Category: Insomnia | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.64 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: Biological | ||||||
| 10/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $26.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: PAIN | ||||||
| 10/09/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Gastroenterology | ||||||
| 10/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 4,432 | 5,520 | $600,388 | $227,836 |
| 2022 | 47 | 4,425 | 5,538 | $624,654 | $232,192 |
| 2021 | 45 | 4,337 | 5,426 | $572,504 | $220,338 |
| 2020 | 42 | 3,470 | 4,136 | $375,599 | $149,521 |
Total Patients
16,664
Total Services
20,620
Medicare Billing
$829,887
Procedure Codes
176
All Medicare Procedures & Services
176 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 436 | 788 | $230,096 | $71,844 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 402 | 402 | $119,796 | $52,360 | 43.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 200 | 201 | $24,522 | $14,359 | 58.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 181 | $37,286 | $11,913 | 31.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 471 | 707 | $21,917 | $7,307 | 33.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 421 | 544 | $21,760 | $7,137 | 32.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 42 | 42 | $15,792 | $7,018 | 44.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 23 | $10,350 | $6,463 | 62.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 203 | 204 | $10,200 | $6,381 | 62.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 288 | 314 | $15,700 | $5,168 | 32.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 31 | $14,477 | $5,148 | 35.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 27 | 27 | $10,179 | $4,521 | 44.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 288 | 456 | $11,400 | $4,341 | 38.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 136 | 141 | $8,460 | $4,090 | 48.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 345 | 403 | $8,060 | $3,067 | 38.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 13 | 13 | $2,964 | $1,700 | 57.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 73 | 77 | $3,080 | $1,388 | 45.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 31 | $3,968 | $1,371 | 34.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 35 | 35 | $3,150 | $1,351 | 42.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 71 | 71 | $2,840 | $1,343 | 47.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 36 | 37 | $1,850 | $1,157 | 62.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 47 | 47 | $2,021 | $876.55 | 43.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 79 | 92 | $1,840 | $813.28 | 44.2% |
| 90471 | Administration of vaccine | Office | 2023 | 51 | 53 | $2,067 | $750.59 | 36.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 64 | $2,048 | $638.96 | 31.2% |
About Dr. Alex Su, MD
Dr. Alex Su, MD is a Family Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609871706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alex Su, MD has received a total of $25,811 in payments from pharmaceutical and medical device companies, with $3,189 received in 2024. These payments were reported across 1,529 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($23,572).
As a Medicare-enrolled provider, Su has provided services to 16,664 Medicare beneficiaries, totaling 20,620 services with total Medicare billing of $829,887. Data is available for 4 years (2020–2023), covering 176 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Houston, TX
- Active Since 06/15/2005
- Last Updated 03/20/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609871706
Products in Payments
- NURTEC ODT (Drug) $1,765
- FARXIGA (Drug) $1,650
- JARDIANCE (Drug) $1,009
- Ozempic (Drug) $1,003
- Vascepa (Drug) $982.82
- MOUNJARO (Drug) $893.81
- XIFAXAN (Drug) $835.70
- XARELTO (Drug) $720.89
- JANUVIA (Drug) $572.84
- UBRELVY (Drug) $553.09
- BREZTRI (Drug) $524.05
- VRAYLAR (Drug) $521.21
- TRULICITY (Drug) $494.26
- TRELEGY ELLIPTA (Drug) $419.03
- Rybelsus (Drug) $365.76
- Azstarys (Drug) $358.92
- ENTRESTO (Drug) $336.65
- INVOKANA (Drug) $331.41
- MYRBETRIQ (Drug) $311.25
- AIRSUPRA (Drug) $308.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Houston
Shannon Schrader, Md, MD
Family Medicine — Payments: $383,042
Family Medicine $383,042
Dr. Eric Nolen, Md, Mba, MD, MBA
Family Medicine — Payments: $158,026
Family Medicine $158,026
Candice Winful, M.d, M.D
Family Medicine — Payments: $123,290
Family Medicine $123,290
Dr. Joe Pouzar, M.d, M.D
Family Medicine — Payments: $104,957
Family Medicine $104,957
Victor Escobar, M.d, M.D
Family Medicine — Payments: $79,840
Family Medicine $79,840
Dr. Oscar De Valle, M.d, M.D
Family Medicine — Payments: $78,226
Family Medicine $78,226